Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2019

01-11-2019 | Original Article

Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model?

Authors: Leonardo Ervolino Corbi, Ana Cristina Aoun Tannuri, Maria Julia de Aro Braz, Vitor Ribeiro Paes, Lourenço Sbragia, Rebeca Lopes Figueira, Karina Miura da Costa, Maria Cecilia Mendonça Coelho, Josiane Oliveira Gonçalves, Suellen Serafini, Uenis Tannuri

Published in: Digestive Diseases and Sciences | Issue 11/2019

Login to get access

Abstract

Background

Biliary cirrhosis is associated with hepatopulmonary syndrome (HPS), which is related to increased posttransplant morbidity and mortality.

Aims

This study aims to analyze the pathophysiology of biliary cirrhosis and the onset of HPS.

Methods

Twenty-one-day-old Wistar rats were subjected to common bile duct ligation and were allocated to two groups: group A (killed 2, 3, 4, 5, or 6 weeks after biliary obstruction) and group B (subjected to biliodigestive anastomosis 2, 3, 4, 5, or 6 weeks after the first procedure and killed 3 weeks later). At the killing, arterial blood was collected for the analyses, and samples from the liver and lungs were collected for histologic and molecular analyses. The gasometric parameters as well as the expression levels of ET-1, eNOS, and NOS genes in the lung tissue were evaluated.

Results

From a total of 42 blood samples, 15 showed hypoxemia (pO2 < 85 mmHg) and 17 showed an increased oxygen gradient [p (A-a) O2 > 18 mmHg]. The liver histology revealed increased ductular proliferation after common bile duct ligation, and reconstruction of bile flow promoted decreased ductular proliferation 5 and 6 weeks post-common bile duct ligation. Pulmonary alterations consisted of decreased parenchymal airspace and increased medial wall thickness. Biliary desobstruction promoted transitory improvements 5 weeks after biliary obstruction (increased parenchymal airspace and decreased MWT—p = 0.003 and p = 0.004, respectively) as well as increased endothelin expression levels (p = 0.009).

Conclusions

The present model showed lung tissue alterations promoted by biliary obstruction. The biliodigestive anastomosis had no clear direct effects on these alterations.
Literature
1.
go back to reference Zhang J, Fallon MB. Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol. 2012;9:539–549.CrossRef Zhang J, Fallon MB. Hepatopulmonary syndrome: update on pathogenesis and clinical features. Nat Rev Gastroenterol Hepatol. 2012;9:539–549.CrossRef
2.
go back to reference Barbe T, Losay J, Grimon G, et al. Pulmonary arteriovenous shunting in children with liver disease. J Pediatr. 1995;126:571–579.CrossRef Barbe T, Losay J, Grimon G, et al. Pulmonary arteriovenous shunting in children with liver disease. J Pediatr. 1995;126:571–579.CrossRef
3.
go back to reference Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB. ERS task force pulmonary-hepatic vascular disorders (PHD) scientific committee. Pulmonary–hepatic vascular disorders (PHD). Eur Respir J. 2004;24:861–880.CrossRef Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB. ERS task force pulmonary-hepatic vascular disorders (PHD) scientific committee. Pulmonary–hepatic vascular disorders (PHD). Eur Respir J. 2004;24:861–880.CrossRef
4.
go back to reference Koch DG, Fallon MB. Hepatopulmonary syndrome. Curr Opin Gastroenterol. 2014;30:260–264.CrossRef Koch DG, Fallon MB. Hepatopulmonary syndrome. Curr Opin Gastroenterol. 2014;30:260–264.CrossRef
6.
go back to reference Chang CC, Chuang CL, Lee FY, et al. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. Clin Sci (Lond). 2013;124:457–466.CrossRef Chang CC, Chuang CL, Lee FY, et al. Sorafenib treatment improves hepatopulmonary syndrome in rats with biliary cirrhosis. Clin Sci (Lond). 2013;124:457–466.CrossRef
7.
go back to reference Chen L, Li YS, Cui J, et al. MiR-206 controls the phenotypic modulation of pulmonary arterial smooth muscle cells induced by serum from rats with hepatopulmonary syndrome by regulating the target gene, annexin A2. Cell Physiol Biochem. 2014;34:1768–1779.CrossRef Chen L, Li YS, Cui J, et al. MiR-206 controls the phenotypic modulation of pulmonary arterial smooth muscle cells induced by serum from rats with hepatopulmonary syndrome by regulating the target gene, annexin A2. Cell Physiol Biochem. 2014;34:1768–1779.CrossRef
8.
go back to reference Xiao R, Goldklang MP, D’Armiento JM. Parenchymal airspace profiling: sensitive quantification and characterization of lung structure evaluating parenchymal destruction. Am J Respir Cell Mol Biol. 2016;55:708–715.CrossRef Xiao R, Goldklang MP, D’Armiento JM. Parenchymal airspace profiling: sensitive quantification and characterization of lung structure evaluating parenchymal destruction. Am J Respir Cell Mol Biol. 2016;55:708–715.CrossRef
9.
go back to reference Shehata SM, Mooi WJ, Okazaki T, El-Banna I, Sharma HS, Tibboel D. Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax. 1999;54:427–431.CrossRef Shehata SM, Mooi WJ, Okazaki T, El-Banna I, Sharma HS, Tibboel D. Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax. 1999;54:427–431.CrossRef
11.
go back to reference Ling Y, Zhang J, Luo B, et al. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology. 2004;39:1593–1602.CrossRef Ling Y, Zhang J, Luo B, et al. The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat. Hepatology. 2004;39:1593–1602.CrossRef
12.
go back to reference de Aro Braz MJ, Corbi LE, Tannuri ACA, et al. Analysis of the reversibility of biliary cirrhosis in young rats submitted to biliary obstruction. J Pediatr Surg. 2018;53:1408–1413.CrossRef de Aro Braz MJ, Corbi LE, Tannuri ACA, et al. Analysis of the reversibility of biliary cirrhosis in young rats submitted to biliary obstruction. J Pediatr Surg. 2018;53:1408–1413.CrossRef
13.
go back to reference Shikata F, Sakaue T, Nakashiro K, et al. Pathophysiology of lung injury induced by common bile duct ligation in mice. PLoS ONE. 2014;14:e94550.CrossRef Shikata F, Sakaue T, Nakashiro K, et al. Pathophysiology of lung injury induced by common bile duct ligation in mice. PLoS ONE. 2014;14:e94550.CrossRef
14.
go back to reference Yang W, Hu B, Wu W, et al. Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS). PLoS One. 2014;24:e113451.CrossRef Yang W, Hu B, Wu W, et al. Alveolar type II epithelial cell dysfunction in rat experimental hepatopulmonary syndrome (HPS). PLoS One. 2014;24:e113451.CrossRef
15.
go back to reference Gómez F, Barberà JA, Roca J, Burgos F, Gistau C, Rodríguez-Roisin R. Effects of nebulized N(G) nitro l-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology. 2006;43:1084–1091.CrossRef Gómez F, Barberà JA, Roca J, Burgos F, Gistau C, Rodríguez-Roisin R. Effects of nebulized N(G) nitro l-arginine methyl ester in patients with hepatopulmonary syndrome. Hepatology. 2006;43:1084–1091.CrossRef
16.
go back to reference Liu L, Zhang M, Luo B, Abrams GA, Fallon MB. Biliary cyst fluid from common bile duct-ligated rats stimulates endothelial nitric oxide synthase in pulmonary artery endothelial cells: a potential role in hepatopulmonary syndrome. Hepatology. 2001;33:722–727.CrossRef Liu L, Zhang M, Luo B, Abrams GA, Fallon MB. Biliary cyst fluid from common bile duct-ligated rats stimulates endothelial nitric oxide synthase in pulmonary artery endothelial cells: a potential role in hepatopulmonary syndrome. Hepatology. 2001;33:722–727.CrossRef
17.
go back to reference Mizumoto M, Arii S, Furutani M, et al. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. J Surg Res. 1997;70:124–133.CrossRef Mizumoto M, Arii S, Furutani M, et al. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. J Surg Res. 1997;70:124–133.CrossRef
Metadata
Title
Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model?
Authors
Leonardo Ervolino Corbi
Ana Cristina Aoun Tannuri
Maria Julia de Aro Braz
Vitor Ribeiro Paes
Lourenço Sbragia
Rebeca Lopes Figueira
Karina Miura da Costa
Maria Cecilia Mendonça Coelho
Josiane Oliveira Gonçalves
Suellen Serafini
Uenis Tannuri
Publication date
01-11-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05658-8

Other articles of this Issue 11/2019

Digestive Diseases and Sciences 11/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.